Science and Development Network
News, views and information about science, technology and the developing world
Did a collapse in mosquito control cause the boom in mosquito numbers?
Flickr/Marcos-Teixeira
[SANTIAGO] Dengue cases in Central and Latin America have increased almost five-fold in incidence in the last 30 years, researchers have found.
There were 4.8 million dengue cases reported to the Pan American Health Organization (PAHO) between 2000 and 2007, compared with 2.7 million in the 1990s and one million in the 1980s.
And the pattern of disease is becoming more severe as children become more vulnerable than adults to the disease — as in South-East Asia. Transmission is now occurring in almost all countries in the region.
Cases of dengue haemorrhagic fever (DHF), a potentially fatal complication, have also increased — from just more than 13,000 cases in the 1980s to more than 100,000 cases between 2000 and 2007.
The authors said this may be because the dengue strain associated with DHF in South-East Asia is more virulent than its American equivalent.
"The pattern of dengue in the Americas is changing, becoming more similar to the Asian profile, with more paediatric cases rather than adult cases," said Olivia Braithwaite, a researcher at the PAHO Regional Program on Dengue and co-author of the study.
She told SciDev.Net that this may be because, as adults are exposed to several types of dengue, they develop resistance to the disease.
Dengue is transmitted primarily by Aedes aegypti mosquitoes and mosquito control is the only prevention method.
The collapse of the regional A. aegypti eradication programme in the 1940s — leading to more mosquitoes since the 1970s — could be behind the escalation, said the researchers.
They call for the implementation of PAHO's Integrated Management Strategy for Dengue Prevention and the development of vaccines to protect against the four types of dengue virus.
Phase II clinical studies on adults and children in Latin America and South-East Asia are being carried out, said Jean Lang, associate vice president and dengue programme leader at Sanofi Pasteur. The vaccine should be launched in 2015–16.
The research was published in the January issue of the American Journal of Tropical Medicine and Hygiene.
American Journal of Tropical Medicine and Hygiene 82, 128 (2010)
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
You need to be signed in to post a comment or to email a consenting comment author. Please sign in or sign up.
Comments
Fouad Oodian ( Mauritius )
8 February 2010
Mark Benedict ( Austria )
8 February 2010
Malcolm Thomas ( United States of America )
19 February 2010